Nanopore detection of single flu viruses to control influenza outbreaks
22 November 2018 | By Drug Target Review
Osaka University researchers have developed a method using single-particle nanopore sensors and AI to detect single influenza virions...
List view / Grid view
Influenza
Tethered antibodies may prevent influenza virus infections
6 November 2018 | By Drug Target Review
Investigational therapeutic candidate made with four antibodies tethered together shows promise against influenza A and B...
Novel DNA vaccine offers broad protection against Influenza-A H3N
19 October 2018 | By Dr Zara Kassam (Drug Target Review)
Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses...
A universal flu vaccine may be in sight
21 September 2018 | By Iqra Farooq (Drug Target Review)
Researchers from Oxford have identified the initial steps on the path towards creating a universal influenza vaccine that could last for life...
Modified-RNA vaccine elicits protective response against influenza
22 August 2018 | By Dr Zara Kassam (Drug Target Review)
A universal flu vaccine that protects people against most influenza strains is one step closer to reality...
C6 gene unlocks mysteries to our immunity
2 July 2018 | By Drug Target Review
Researchers have identified a new gene that plays a critical role in regulating the body's immune response to infection and disease...
Researchers reveal therapeutic target for Influenza A
25 June 2018 | By Drug Target Review
Researchers show altering the molecular interactions between the flu virus and host genes stunts virus replication...
Researchers uncover origin of virus-fighting plasma B cells
19 April 2018 | By Drug Target Review
A group of researchers have discovered an important mechanism that governs how B cells are chosen to become plasma cells...
Influenza viruses can help mutated viral proteins fold and function
27 September 2017 | By Dr Zara Kassam (Drug Target Review)
A new study from has shed light on just how viruses evolve so quickly and offers a potential way to slow them down...
RNA cells genetically re-programmed to fight cancer
19 September 2017 | By Dr Zara Kassam (Drug Target Review)
RNA cells can be genetically programmed like a computer to fight cancer, influenza, and other serious conditions...
Anti-inflammatory drugs could treat symptoms of depression
18 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Anti-inflammatory drugs, like those used to treat rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression...
Flu vaccines fail to protect obese mice
8 August 2016 | By St. Jude Children’s Research Hospital
Using vaccines prepared from killed viruses, the scientists targeted an influenza A H1N1 seasonal flu strain, finding that obese mice are not protected against influenza infections through vaccines, raising concerns about vaccine response in obese humans, who are known to be at an increased risk for severe flu...
Inducing antibodies could lead to a universal flu vaccine
25 July 2016 | By Niamh Louise Marriott, Digital Content Producer
Scientists have identified three types of vaccine-induced antibodies that can neutralise diverse strains of the flu virus that infect so many each year...
Programmable RNA vaccines effective against Ebola and influenza
4 July 2016 | By Victoria White, Digital Content Producer
MIT engineers have developed easily customisable RNA vaccines that can be manufactured in one week and have shown efficacy against ebola and H1N1 influenza...
A vaccine that protects against multiple H1N1 influenza strains
29 March 2016 | By Victoria White
Using a technique called COBRA, researchers created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza strains...
Follow: